| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 05/17/2012 | US20120123365 Absorbent Article with Philic Anhydrous Lotion |
| 05/17/2012 | US20120123182 Devices for thermally induced transformations controlled by irradiation of functionalized fullerenes |
| 05/17/2012 | US20120123065 Hydrolytically Stable Maleimide-Terminated Polymers |
| 05/17/2012 | US20120122997 New polysaccharide-based materials |
| 05/17/2012 | US20120122996 Azeotrope-like compositions comprising 1-chloro-3,3,3-trifluoropropene |
| 05/17/2012 | US20120122967 Compositions and products containing r-equol, and methods for their making |
| 05/17/2012 | US20120122845 Method for the production of bioadhesive compact matrices |
| 05/17/2012 | US20120122829 Pharmaceutical composition for transdermal or transmucous administration |
| 05/17/2012 | US20120122788 E-polylysine conjugates and the use thereof |
| 05/17/2012 | US20120121711 Microsphere drug carrier, preparation method, composition and use thereof |
| 05/17/2012 | US20120121709 Phase transition biopolymers and methods of use |
| 05/17/2012 | US20120121695 Acoustically sensitive drug delivery particles comprising non-lamellar forming phosphatidylethanolamine |
| 05/17/2012 | US20120121690 Method to enhance an immune response of nucleic acid vaccination |
| 05/17/2012 | US20120121674 Nonwoven fabric products with enhanced transfer properties |
| 05/17/2012 | US20120121668 Compositions for oral adminstration of active principles requiring masking of taste |
| 05/17/2012 | US20120121666 Compositions of particles |
| 05/17/2012 | US20120121665 Implantable or insertable medical device resistant to microbial growth and biofilm formation |
| 05/17/2012 | US20120121663 Treatment using dantrolene |
| 05/17/2012 | US20120121662 Treatment using dantrolene |
| 05/17/2012 | US20120121657 Enhancing biocompatibility of a medical device |
| 05/17/2012 | US20120121644 Sticky soft gel for treating poultry |
| 05/17/2012 | US20120121623 Novel antipathogenic peptides |
| 05/17/2012 | US20120121622 Biodegradable immunomodulatory formulations and methods for use thereof |
| 05/17/2012 | US20120121606 Antibodies that immunospecifically bind to b lymphocyte stimulator protein |
| 05/17/2012 | US20120121601 Mammalian receptor proteins; related reagents and methods |
| 05/17/2012 | US20120121599 Compositions and methods for stem cell delivery |
| 05/17/2012 | US20120121518 Multifunctional imaging and therapeutic nanoparticles |
| 05/17/2012 | US20120121517 Biodegradable and thermosensitive poly(organophosphazene)-superparamagnetic nanoparticle complex, preparation method and use thereof |
| 05/17/2012 | US20120121501 Hmgn2 peptides and related molecules that selectively home to tumor blood vessels and tumor cells |
| 05/16/2012 | EP2452685A1 Buffered compositions for dialysis |
| 05/16/2012 | EP2452684A2 Micelles |
| 05/16/2012 | EP2452673A2 Chitosan gel for dermatological use, production method therefor and use of same |
| 05/16/2012 | EP2452561A1 Material, item and products comprising a composition having anti-microbial properties |
| 05/16/2012 | EP2452559A1 Material, item and products comprising a composition having anti-microbial properties |
| 05/16/2012 | EP2452558A1 Material, item and products comprising a composition having anti-microbial properties |
| 05/16/2012 | EP2451859A1 Solid linear oligo-or poly-e-caprolactone derivatives |
| 05/16/2012 | EP2451839A1 Method for the production of variable domains |
| 05/16/2012 | EP2451486A1 Pegylated l-asparaginase |
| 05/16/2012 | EP2451484A1 Biopolymer hybrid gel-depot delivery system |
| 05/16/2012 | EP2451483A1 Peracid/peroxide composition, process for accurately making the same, and method for use as an evaporating film anti-microbial solution and as a photosensitizer |
| 05/16/2012 | EP2451480A1 A complex of bi-specific antibody and digoxigenin conjugated to a therapeutic or diagnostic agent |
| 05/16/2012 | EP2451479A1 Bi-specific digoxigenin binding antibodies |
| 05/16/2012 | EP2451463A2 Ophthalmic ethyleneoxide butyleneoxide block copolymer compositions |
| 05/16/2012 | EP2451460A1 Liquid pharmaceutical form of alkylphosphocholine and method of preparing same |
| 05/16/2012 | EP2451458A2 Pharmaceutical compositions and solid forms |
| 05/16/2012 | EP2451442A1 Matrix carrier compositions, methods and uses |
| 05/16/2012 | EP2451439A1 Composition comprising bioactive amino acids and/or peptides and marine oil in a stable oil-in-water emulsion, and the use of said composition as a functional or therapeutic composition |
| 05/16/2012 | EP2451438A2 Pharmaceutical composition for a hepatitis c viral protease inhibitor |
| 05/16/2012 | EP2451437A2 Aqueous preparations comprising methionine |
| 05/16/2012 | EP2451436A1 Method and pharmaceutical compositions for trans-buccal mucosa treatment of postprandial hyperglycaemia in type ii diabetes |
| 05/16/2012 | EP2451284A1 Novel gold-based nanocrystals for medical treatments and electrochemical manufacturing processes therefor |
| 05/16/2012 | EP2244693B1 Agent for intra-articular injection |
| 05/16/2012 | EP1909775B1 Formulation of radioprotective alpha, beta unsaturated aryl sulfones |
| 05/16/2012 | CN1867357B Conjugate of a photosensitiser and a bacteriophage |
| 05/16/2012 | CN102459351A 多糖类衍生物及其水凝胶 Polysaccharide derivatives and hydrogels |
| 05/16/2012 | CN102459348A 用于将gdnf和bdnf递送至中枢神经系统的融合蛋白 Fusion protein is used to gdnf and bdnf delivered to the central nervous system |
| 05/16/2012 | CN102458555A Rejuvenating coronary artery by improving blood flow with the help of insertion of nano-balls (encapsulated nanoparticles) containing therapeutic agents by non implantable device for tissues and thereby providing in tissue release to address the requ |
| 05/16/2012 | CN102458479A Methods for identification of sites for igg conjugation |
| 05/16/2012 | CN102458478A Albumin-amyloid peptide conjugates and uses thereof |
| 05/16/2012 | CN102458477A Anti-mesothelin immunoconjugates and uses therefor |
| 05/16/2012 | CN102458476A 用于治疗多发性硬化症的组合物及方法 Treatment of multiple sclerosis compositions and methods for |
| 05/16/2012 | CN102458475A Dry-coated orally-disintegrating tablet |
| 05/16/2012 | CN102458474A Treatment of acinetobacter with alginate oligomers and antibiotics |
| 05/16/2012 | CN102458451A 血红蛋白组合物 Hemoglobin composition |
| 05/16/2012 | CN102458423A 胶原产生促进剂 Collagen production promoting agent |
| 05/16/2012 | CN102458406A Oral liquid preparation |
| 05/16/2012 | CN102458388A Semi-solid compositions and pharmaceutical products |
| 05/16/2012 | CN102458382A Oil-in-water emulsion of mometasone and propylene glycol |
| 05/16/2012 | CN102458374A Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same |
| 05/16/2012 | CN102458373A Microspheres with improved bioavailability containing poorly water-soluble drugs, and method for preparing same |
| 05/16/2012 | CN102458369A Compositions and methods for drug delivery |
| 05/16/2012 | CN102458368A Solid pharmaceutical preparations containing copolymers based on polyethers combined with poorly water-soluble polymers |
| 05/16/2012 | CN102458361A Lipid formulation of apoptosis promoter |
| 05/16/2012 | CN102458359A Microneedle device |
| 05/16/2012 | CN102453244A Temperature sensitive biodegradable poly(poly ether-ester diacid)anhydride multiblock copolymer, and hydrogel system and application thereof |
| 05/16/2012 | CN102453095A Fusion protein containing GLP (glucagon-like peptide)-1 and preparation method and application thereof |
| 05/16/2012 | CN102453094A Fusion protein containing Exendin-4 and preparation method and application thereof |
| 05/16/2012 | CN102453089A Preparation and application of recombinant consensus interferon mutant polyethylene glycol conjugate |
| 05/16/2012 | CN102451471A Polyethyleneglycol-staphylokinase conjugate as well as preparing method and application thereof |
| 05/16/2012 | CN102451470A Oxymatrine phosphatide compound and preparation method and application thereof |
| 05/16/2012 | CN102451469A High-efficiency stabilizing agent for hard-soluble medicine nanometer system |
| 05/16/2012 | CN102451468A SiO2 mesoporous hollow nanosphere carrier and preparation and application thereof |
| 05/16/2012 | CN102451463A Naja naja atra analgesic peptide transdermal preparation |
| 05/16/2012 | CN102451429A Method for preparing Ruan Pian |
| 05/16/2012 | CN102451366A Anti-arrhythmia traditional Chinese medicine capsule |
| 05/16/2012 | CN102451264A Medicinal preparation for treating chronic gastritis and gastroduodenal ulcer and preparation method thereof |
| 05/16/2012 | CN102451189A Donkey-hide gelatin injection and preparation method thereof |
| 05/16/2012 | CN102451184A Long-acting compound doxycycline injection |
| 05/16/2012 | CN102451181A Prescription and preparation method of injection lansoprazole |
| 05/16/2012 | CN102451176A Docetaxel/steroid composite |
| 05/16/2012 | CN102451173A Tiotropium bromide capsule-type inhalation aerosol powder |
| 05/16/2012 | CN102451172A Transdermal patch for relieving pain, and preparation method thereof |
| 05/16/2012 | CN102451169A Loratadine lyophilized tablets and preparation method thereof |
| 05/16/2012 | CN102451165A Rotundine orally disintegrating tablets and preparation method thereof |
| 05/16/2012 | CN102451164A Analgesic oral cavity disintegrating tablet and preparation method thereof |
| 05/16/2012 | CN102451163A Polyporus polysaccharide dispersible tablets, and preparation method thereof |
| 05/16/2012 | CN102451160A Preparation method of long-circulating nanoparticle |
| 05/16/2012 | CN102451158A Nimodipine-SiO2 nanospheres and preparation and application thereof |
| 05/16/2012 | CN102451157A Docetaxel submicron emulsion with steroid composite as intermediate carrier |
| 05/16/2012 | CN102451156A Gemcitabine hydrochloride injection preparation and its preparation method |